1. Home
  2. GECC vs CPIX Comparison

GECC vs CPIX Comparison

Compare GECC & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GECC

Great Elm Capital Corp.

N/A

Current Price

$6.11

Market Cap

84.6M

Sector

Finance

ML Signal

N/A

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

N/A

Current Price

$8.67

Market Cap

92.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GECC
CPIX
Founded
2016
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
84.6M
92.3M
IPO Year
2016
2007

Fundamental Metrics

Financial Performance
Metric
GECC
CPIX
Price
$6.11
$8.67
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.75
N/A
AVG Volume (30 Days)
49.8K
94.6K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
22.06%
N/A
EPS Growth
N/A
58.70
EPS
0.41
N/A
Revenue
N/A
$42,010,949.00
Revenue This Year
$0.92
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.61
N/A
Revenue Growth
N/A
16.75
52 Week Low
$4.63
$1.85
52 Week High
$11.45
$9.28

Technical Indicators

Market Signals
Indicator
GECC
CPIX
Relative Strength Index (RSI) 62.23 65.14
Support Level $5.38 $5.55
Resistance Level $6.34 N/A
Average True Range (ATR) 0.18 0.50
MACD 0.02 0.08
Stochastic Oscillator 80.56 72.17

Price Performance

Historical Comparison
GECC
CPIX

About GECC Great Elm Capital Corp.

Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generates both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses. The Company operates as a single reportable segment with an investment objective to generate both current income and capital appreciation through debt and equity investments and manages the business on a consolidated basis.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.

Share on Social Networks: